Jathin Bandari - Jul 1, 2022 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
Chief Medical Officer
Signature
/s/ Mary Grendell, Attorney-in-Fact
Stock symbol
TARA
Transactions as of
Jul 1, 2022
Transactions value $
-$2,196
Form type
4
Date filed
7/5/2022, 05:00 PM
Previous filing
Jan 12, 2022
Next filing
Jan 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Tax liability -$2.2K -682 -3.25% $3.22 20.3K Jul 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on July 1, 2020.